Molecular Imaging 2017

Previous Page

Next Page

Page Background

Impact of MRI

Source

Patients

No

CRM +ve rate

Leeds cohort

1986-1997

All rectal cancers 561

27%

Dutch TME trial

1996-2000

Mobile rectal

cancers

180

22%

MERCURY trial

2002-2003

All rectal cancers 428

16%